Translational Gastrointestinal Oncology and Preclinical Models
- DKFZ Hector Cancer Institute
- Functional and Structural Genomics
- Clinical Cooperation Unit
- Junior Research Group
apl. Prof. Dr. Johannes Betge
Group Leader
Curing advanced cancers of the digestive tract remains a major challenge. We contribute to improving the treatment of these diseases by gaining insights into cancer biology and therapy resistance mechanisms using cutting-edge high-throughput approaches with patient-derived tumor models and by translating these findings to bedside through innovative clinical trials.
Image: Patient derived organoids from a colorectal cancer patient, DNA (magenta), actin cytoskeleton (cyan), dead cells (yellow). | © dkfz.de,
Image: Patient derived organoids from a colorectal cancer patient, DNA (magenta), actin cytoskeleton (cyan), dead cells (yellow). | © dkfz.de,
Our Research
Tumors of the digestive tract are among the most common cancers worldwide. Despite significant advances in cancer therapy, curing patients with metastatic tumors remains a major challenge. The overarching goal of our research group is to develop novel, personalized therapies for patients with gastrointestinal tumors and to establish new predictive factors that can better forecast responses to cancer treatments.